Literature DB >> 19279422

Implication of adenomatous polyposis coli and MUTYH mutations in familial colorectal polyposis.

Marina De Rosa1, Martina Galatola, Santa Borriello, Francesca Duraturo, Stefania Masone, Paola Izzo.   

Abstract

PURPOSE: Familial adenomatous polyposis is an autosomal dominantly inherited syndrome characterized by hundreds or thousands of colorectal polyps and a high risk of colorectal cancer at a young age. Truncating germline mutations in the adenomatous polyposis coli gene are detected in approximately 80 percent of patients with classical familial adenomatous polyposis and in approximately 10 percent of the attenuated familial adenomatous polyposis patients.
METHODS: We investigated the adenomatous polyposis coli and MUTYH genes mutations in a well-characterized series of 25 unrelated Italian patients with familial adenomatous polyposis.
RESULTS: We characterized the specific adenomatous polyposis coli gene mutation in 10 probands, and identified eight truncating mutations (4 novel and 4 known mutations) and two splicing mutations. One of these, a novel missense mutation in exon 15, activates an exonic splicing enhancer control sequence. Moreover, 11 MUTYH gene mutations have been identified in 7 patients without a dominant family history of polyposis.
CONCLUSIONS: This study enlarges the genotype-phenotype correlations of familial adenomatous polyposis and suggests that messenger alterations could be responsible for a subset of familial adenomatous polyposis cases without germ-line adenomatous polyposis coli or MUTYH gene mutations. It also confirms that genotype-phenotype correlations in MUTYH-associated polyposis are very complex.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19279422     DOI: 10.1007/DCR.0b013e318197d15c

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  12 in total

Review 1.  TTD consensus document on the diagnosis and management of hereditary colorectal cancer.

Authors:  Pedro Pérez Segura; Carmen Guillén Ponce; Carmen Guillén Alonso; Teresa Ramón y Cajal; Raquel Serrano Blanch; Enrique Aranda
Journal:  Clin Transl Oncol       Date:  2010-05       Impact factor: 3.405

2.  Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis.

Authors:  Martina Galatola; Erasmo Miele; Caterina Strisciuglio; Lorella Paparo; Daniela Rega; Paolo Delrio; Francesca Duraturo; Massimo Martinelli; Giovanni Battista Rossi; Annamaria Staiano; Paola Izzo; Marina De Rosa
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

3.  Beta catenin and cytokine pathway dysregulation in patients with manifestations of the "PTEN hamartoma tumor syndrome".

Authors:  Martina Galatola; Lorella Paparo; Francesca Duraturo; Mimmo Turano; Giovanni Battista Rossi; Paola Izzo; Marina De Rosa
Journal:  BMC Med Genet       Date:  2012-04-20       Impact factor: 2.103

Review 4.  Multiple splenic hamartomas and familial adenomatous polyposis: a case report and review of the literature.

Authors:  Nicola Carlomagno; Francesca Duraturo; Maria Candida; Marina De Rosa; Valeria Varone; Giuseppe Ciancia; Armando Calogero; Michele L Santangelo
Journal:  J Med Case Rep       Date:  2015-07-04

5.  Differential expression of PTEN gene correlates with phenotypic heterogeneity in three cases of patients showing clinical manifestations of PTEN hamartoma tumour syndrome.

Authors:  Paola Izzo; Marina De Rosa; Lorella Paparo; Giovanni Battista Rossi; Paolo Delrio; Daniela Rega; Francesca Duraturo; Raffaella Liccardo; Mario Debellis
Journal:  Hered Cancer Clin Pract       Date:  2013-07-25       Impact factor: 2.857

6.  Incomplete Segregation of MSH6 Frameshift Variants with Phenotype of Lynch Syndrome.

Authors:  Raffaella Liccardo; Marina De Rosa; Giovanni Battista Rossi; Nicola Carlomagno; Paola Izzo; Francesca Duraturo
Journal:  Int J Mol Sci       Date:  2017-05-06       Impact factor: 5.923

Review 7.  Novel Implications in Molecular Diagnosis of Lynch Syndrome.

Authors:  Raffaella Liccardo; Marina De Rosa; Paola Izzo; Francesca Duraturo
Journal:  Gastroenterol Res Pract       Date:  2017-01-29       Impact factor: 2.260

8.  Novel MSH2 splice-site mutation in a young patient with Lynch syndrome.

Authors:  Raffaella Liccardo; Marina De Rosa; Paola Izzo; Francesca Duraturo
Journal:  Mol Med Rep       Date:  2018-03-15       Impact factor: 2.952

9.  Contribution of large genomic rearrangements in Italian Lynch syndrome patients: characterization of a novel alu-mediated deletion.

Authors:  Francesca Duraturo; Angela Cavallo; Raffaella Liccardo; Bianca Cudia; Marina De Rosa; Giuseppe Diana; Paola Izzo
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

10.  Same MSH2 Gene Mutation But Variable Phenotypes in 2 Families With Lynch Syndrome: Two Case Reports and Review of Genotype-Phenotype Correlation.

Authors:  Raffaella Liccardo; Marina De Rosa; Francesca Duraturo
Journal:  Clin Med Insights Case Rep       Date:  2018-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.